Newsroom
  • Press Releases
  • Presentations
Investors
  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • Notice to Stockholders
  • News / Events
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
Clinical Trial Enrollment
  • COVID-19 Long-Haulers
  • COVID-19 Mild to Moderate
  • COVID-19 Severe or Critical
  • Nonalcoholic Steatohepatitis (NASH)
  • Triple-Negative Breast Cancer
Contact

CytoDyn Inc.

  • Home
  • About CytoDyn
    • Meet CytoDyn
  • Our Science
  • Pipeline
    • Overview
    • HIV
    • Cancer
    • GVHD
    • COVID-19
  • Our Team
    • Management Team
    • Board of Directors
  • Careers
    • Now Hiring
  • Scientific Board of Advisors
  • Newsroom
  • Investors
  • Clinical Trial Enrollment
  • Contact
Latest News

FOR THE LATEST DEVELOPING NEWS Click Here

Enrollment Locations for Open Label Extension (OLE)

Dr. Yang – Leronlimab in IDSA Publication

Recent Progress and Expectations in Oncology, COVID-19, and other Programs

Brazil has approved critically ill COVID Phase 3 to begin

Leronlimab COVID-19 Brazil Trial enrolled the first patient

Leronlimab’s Mechanism of Action in COVID-19 Published

Leronlimab and Glioblastoma - Published April 2021

Experimental Drugs Aim to Treat Long-Haul Covid Patients

Leronlimab Published in Journal of Translational Autoimmunity

Nature Communications: Leronlimab and HIV
Case Study - Journal of Translational Autoimmunity

Dr. Seethamraju - Special isirv-AVG Virtual Conference

TNBC Presentation – Dr. Kelly

Leronlimab Potential in HIV PrEP

CytoDyn presents to large gathering of medical staff in different hospitals in Philippines

Long-Hauler Trial Endpoints

Oncology Presentation

Emerging Growth Conference – October 13

CCR5 closes the 1 temporal window for memory linking

CD15 Patients’ Testimonies

Historical Data

Investors

Investors

  • Overview
  • Warrant Exercise Inquiries
  • Restricted Stock Inquiries
  • Notice to Stockholders
  • News / Events
    • Overview
    • Press Releases
    • In The News
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents

  • Stock Data

  • Quote
  • Charts
  • Historical Data
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
© 2021 CytoDyn Inc. All Rights Reserved.
  • Twitter
  • Facebookj
Privacy Policy Disclaimer Sitemap

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.